Weijun Z. Fan

651 Dongfeng East Rd
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Hepatic arterial infusion or intravenous infusion of adebrelimab, combined with bevacizumab and HAIC of the FOLFOX regimen for advanced unresectable hepatocellular carcinoma (HAIBrave-001 trial): a study protocol of a prospective, double-arm, phase II trial.

Hepatic arterial infusion or intravenous infusion of adebrelimab, combined with bevacizumab and HAIC of the FOLFOX regimen for advanced unresectable hepatocellular carcinoma (HAIBrave-001 trial): a study protocol of a prospective, double-arm, phase II trial.

Journal: Journal of gastrointestinal oncology

Published: June 02, 2026

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein.

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein.

Journal: Journal of visualized experiments : JoVE

Published: February 02, 2026

Noninvasive Profiling for PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.

Noninvasive Profiling for PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.

Journal: Radiology

Published: January 13, 2026

Transarterial chemoembolisation-based combination therapy as a potential new standard for intermediate-stage hepatocellular carcinoma in the targeted immunotherapy era.

Transarterial chemoembolisation-based combination therapy as a potential new standard for intermediate-stage hepatocellular carcinoma in the targeted immunotherapy era.

Journal: BMJ open gastroenterology

Published: October 29, 2025

Global research trends and foci of ablation therapies for liver tumours: a scientometric study.

Global research trends and foci of ablation therapies for liver tumours: a scientometric study.

Journal: Journal of gastrointestinal oncology

Published: September 12, 2025

Consensus from the Asian conference on tumor ablation working group on image-guided thermal ablation for lung tumor: 10 key questions and answers.

Consensus from the Asian conference on tumor ablation working group on image-guided thermal ablation for lung tumor: 10 key questions and answers.

Journal: Journal of cancer research and therapeutics

Published: August 11, 2025

Thermal ablation versus hepatectomy in patients with liver metastases from RAS-mutated colorectal cancer.

Thermal ablation versus hepatectomy in patients with liver metastases from RAS-mutated colorectal cancer.

Journal: Journal of cancer research and therapeutics

Published: July 19, 2025

Comparative effectiveness of thermal ablation, radiotherapy, and surgery for adrenal metastases: a multi-institutional cohort study.

Comparative effectiveness of thermal ablation, radiotherapy, and surgery for adrenal metastases: a multi-institutional cohort study.

Journal: European radiology

Published: July 13, 2025

TACE combined with regorafenib with or without anti-PD-1 therapy for advanced HCC after targeted therapy failure: a multicenter real-world study.

TACE combined with regorafenib with or without anti-PD-1 therapy for advanced HCC after targeted therapy failure: a multicenter real-world study.

Journal: Frontiers in oncology

Published: June 23, 2025

Diagnostic accuracy of dual-phase cone-beam computed tomography for celiac arteriography in patients with hepatocellular carcinoma: Comparison with preoperative dynamic contrast-enhanced magnetic resonance imaging.

Diagnostic accuracy of dual-phase cone-beam computed tomography for celiac arteriography in patients with hepatocellular carcinoma: Comparison with preoperative dynamic contrast-enhanced magnetic resonance imaging.

Journal: Journal of cancer research and therapeutics

Published: May 09, 2025

Efficacy and safety of adebrelimab plus bevacizumab in combination with hepatic artery infusion chemotherapy for advanced stage hepatocellular carcinoma: a retrospective cohort study.

Efficacy and safety of adebrelimab plus bevacizumab in combination with hepatic artery infusion chemotherapy for advanced stage hepatocellular carcinoma: a retrospective cohort study.

Journal: Neoplasma

Published: May 08, 2025

Development and validation of the NTAA prognostic model for BCLC stage B hepatocellular carcinoma undergoing transarterial chemoembolization: a retrospective multicenter cohort study.

Development and validation of the NTAA prognostic model for BCLC stage B hepatocellular carcinoma undergoing transarterial chemoembolization: a retrospective multicenter cohort study.

Journal: International journal of surgery (London, England)

Published: April 23, 2025

Showing 1-12 of 93

Last Updated: 09/26/2026